Impact of frailty on post-procedural adverse outcomes in older adults aged ≥75 years undergoing percutaneous coronary intervention: a systematic review of observational studies

• by Peng Tian, Liping Wang, Tianjiao He, Qiurong Zhang, Yingying Cai

• May 14, 2026

New Label Expansion in Generalized Myasthenia Gravis

Phase 3 ADAPT SERON data supported efgartigimod use across antibody subtypes often underrepresented in trials.

• by Kathryn Wighton

• May 11, 2026

• 2 min

Baptist Health Miami Neuroscience Institute Advances Parkinson’s Disease Imaging With Specialized MRI Protocol

Diagnosing Parkinson’s disease has long depended primarily on clinical expertise — careful neurologic examination, longitudinal symptom assessment and the nuanced interpretation of movement abnormalities.

• by

• May 11, 2026

• 5 min

Innovative, Minimally Invasive Treatment for Drug-Resistant Epilepsy

Epilepsy remains a life-altering condition, particularly due to the unpredictable nature of seizures and their cumulative impact on cognition, independence and quality of life.

• by

• May 8, 2026

• 5 min